Literature DB >> 19521016

Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Sanae Hamaguchi1, Miyuki Tsuchihashi-Makaya, Shintaro Kinugawa, Takashi Yokota, Tomomi Ide, Akira Takeshita, Hiroyuki Tsutsui.   

Abstract

BACKGROUND: Previous studies have demonstrated that renal dysfunction is common in patients with heart failure (HF), but it is not known whether chronic kidney disease (CKD) is associated with increased risks of long-term adverse outcomes in unselected HF patients encountered in current routine clinical practice in Japan. METHODS AND
RESULTS: The Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD) prospectively studied a broad sample of patients hospitalized with worsening HF and their outcomes with an average of 2.4 years of follow-up. The study cohort (n=2,013) were classified into 3 groups by estimated glomerular filtration rate (eGFR): > or =60 (n=579), 30-59 (n=1,025), and <30 ml x min(-1) x 1.73 m(-2) or patients with dialysis (n=409); 1,372 patients (70.3%) had an eGFR <60 ml x min(-1) x 1.73 m(-2) and 62 patients were treated with dialysis. The multivariable adjusted risk for all-cause death or rehospitalization increased with reduced eGFR; an adjusted hazard ratio (HR) 1.520 (95% confidence interval (CI) 1.186-1.949) for eGFR 30-59 ml x min(-1) x 1.73 m(-2) (P=0.001) and HR 2.566 (95%CI 1.885-3.492) for eGFR <30 ml x min(-1) x 1.73 m(-2) or patients with dialysis (P<0.001).
CONCLUSIONS: CKD is common in HF and was independently associated with long-term adverse outcomes in a broad cohort of Japanese patients.

Entities:  

Mesh:

Year:  2009        PMID: 19521016     DOI: 10.1253/circj.cj-09-0062

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  27 in total

1.  Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients.

Authors:  Yuya Matsue; Akihiko Matsumura; Masami Abe; Maki Ono; Mie Seya; Tomofumi Nakamura; Ryota Iwatsuka; Akira Mizukami; Masahiko Setoguchi; Wataru Nagahori; Masakazu Ohno; Makoto Suzuki; Yuji Hashimoto
Journal:  Heart Vessels       Date:  2011-12-10       Impact factor: 2.037

2.  High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction.

Authors:  Yuichi Kimura; Yasuhiro Izumiya; Shinsuke Hanatani; Eiichiro Yamamoto; Hiroaki Kusaka; Takanori Tokitsu; Seiji Takashio; Kenji Sakamoto; Kenichi Tsujita; Tomoko Tanaka; Megumi Yamamuro; Sunao Kojima; Shinji Tayama; Koichi Kaikita; Seiji Hokimoto; Hisao Ogawa
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

3.  Weekend versus weekday hospital admission and outcomes during hospitalization for patients due to worsening heart failure: a report from Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

Authors:  Sanae Hamaguchi; Shintaro Kinugawa; Miyuki Tsuchihashi-Makaya; Daisuke Goto; Hiroyuki Tsutsui
Journal:  Heart Vessels       Date:  2013-05-08       Impact factor: 2.037

4.  Malnutrition, renal dysfunction and left ventricular hypertrophy synergistically increase the long-term incidence of cardiovascular events.

Authors:  Keisuke Maruyama; Naoki Nakagawa; Erika Saito; Motoki Matsuki; Naofumi Takehara; Kazumi Akasaka; Nobuyuki Sato; Naoyuki Hasebe
Journal:  Hypertens Res       Date:  2016-05-12       Impact factor: 3.872

5.  Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention.

Authors:  Manabu Ogita; Kenichi Sakakura; Tomohiro Nakamura; Hiroshi Funayama; Hiroshi Wada; Ryo Naito; Yoshitaka Sugawara; Norifumi Kubo; Junya Ako; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2011-08-06       Impact factor: 2.037

6.  Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease.

Authors:  Yusuke Nakade; Tadashi Toyama; Kengo Furuichi; Shinji Kitajima; Noriyuki Ohkura; Akihiro Sagara; Yasuyuki Shinozaki; Akinori Hara; Kiyoki Kitagawa; Miho Shimizu; Yasunori Iwata; Hiroyasu Oe; Mikio Nagahara; Hiroshi Horita; Yoshio Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-12-15       Impact factor: 2.801

Review 7.  Pathogenesis and therapeutic implications of cardiorenal syndrome.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2010-11-23       Impact factor: 2.801

8.  The influence of renal insufficiency on sleep-disordered breathing in patients with symptomatic chronic heart failure.

Authors:  Umpei Yamamoto; Masahiro Mohri
Journal:  Exp Clin Cardiol       Date:  2010

9.  Effect of subcutaneous oxycodone for end-stage heart failure due to severe aortic stenosis - A case report.

Authors:  Shutaro Futami; Joji Ishikawa; Yukari Arima; Yukiko Mogami; Yoshiko Nemoto; Jun Tanaka; Eiichi Saito; Kazumasa Harada
Journal:  J Cardiol Cases       Date:  2018-03-05

10.  Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study.

Authors:  Keisuke Kida; Yugo Shibagaki; Naoto Tominaga; Naoki Matsumoto; Yoshihiro J Akashi; Fumihiko Miyake; Kenjiro Kimura
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.